“Global Antimicrobial Suture Market to reach a market value of 367.5 Million by 2031 growing at a CAGR of 3.5%”
The Global Antimicrobial Suture Market size is expected to reach $367.5 million by 2031, rising at a market growth of 3.5% CAGR during the forecast period.
North America, especially the United States and Canada, has some of the most advanced healthcare systems in the world. The emphasis on high standards of care drives the adoption of advanced medical products, including antimicrobial sutures, to ensure the best outcomes for patients. The region strongly focuses on infection control measures in hospitals and outpatient settings. Antimicrobial sutures meet these stringent infection control standards and prevent complications from surgical site infections. Thus, the North America 37% region acquired revenue share in the market 2023.
Hospitals and surgical centers are increasingly adopting stringent infection control protocols to improve patient safety and minimize the risk of postoperative infections. Antimicrobial sutures play a crucial role in these protocols by reducing the incidence of infections at the surgical site.
Additionally, as healthcare expenditure rises, there is greater investment in advanced medical technologies and products, including antimicrobial sutures. Healthcare facilities with increased budgets can afford to incorporate the latest innovations, such as antimicrobial sutures, to improve patient care and infection control.
However, many healthcare facilities, especially those with limited budgets, may struggle to justify the higher cost of antimicrobial sutures compared to traditional sutures. Budget constraints can limit the ability of these facilities to invest in advanced technologies, potentially leading to a preference for more cost-effective alternatives. Thus, the high cost of antimicrobial sutures hampers the market's growth.
The pandemic caused interruptions in clinical trials and research for new antimicrobial sutures. Delays in research and development affected the progress of innovative products and solutions. With a shift in focus towards COVID-19-related research, developing and testing antimicrobial sutures faced delays. This shift impacted on the introduction of new and improved products in the market. Thus, the COVID-19 pandemic had a negative impact on the market.
On the basis of end user, the market is segmented into hospitals, clinics, and others. The hospitals segment recorded 68% revenue share in the market in 2023. Hospitals perform many surgeries daily across various specialties, including general surgery, orthopedics, cardiology, and gynecology.
Based on type, the market is divided into absorbable and non-absorbable. The non-absorbable segment procured 33% revenue share in the market in 2023. Non-absorbable sutures provide long-term support for tissues that require prolonged stabilization, making them ideal for high-tension areas or where long-term durability is essential.
Free Valuable Insights: Global Antimicrobial Suture Market size to reach USD 367.5 Million by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the market. With the growth of healthcare facilities and advancements in medical technology, there has been an increase in the number of surgical procedures performed in the Asia-Pacific region.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 282.6 Million |
| Market size forecast in 2031 | USD 367.5 Million |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 3.5% from 2024 to 2031 |
| Number of Pages | 183 |
| Number of Tables | 250 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Type, End User, Region |
| Country scope |
|
| Companies Included | Conmed Corporation, Smith & Nephew plc, Demetech Corporation, Medtronic PLC, B. Braun Melsungen AG, W. L. Gore & Associates, Inc., Boston Scientific Corporation, Johnson & Johnson, Peters Surgical and Stryker Corporation |
By Type
By End User
By Geography
The Market size is projected to reach USD 367.5 million by 2031.
Growing focus on infection control protocols are driving the Market in coming years, however, High cost of antimicrobial sutures restraints the growth of the Market.
Conmed Corporation, Smith & Nephew plc, Demetech Corporation, Medtronic PLC, B. Braun Melsungen AG, W. L. Gore & Associates, Inc., Boston Scientific Corporation, Johnson & Johnson, Peters Surgical and Stryker Corporation
The expected CAGR of this Market is 3.5% from 2024 to 2031.
The Absorbable segment is leading the Market by Type in 2023; thereby, achieving a market value of $238.3 million by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $133.8 million by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 